文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

机械功率按预测体重归一化可预测急性呼吸窘迫综合征患者死亡率

Mechanical power normalized to predicted body weight as a predictor of mortality in patients with acute respiratory distress syndrome.
PubMed 文献 · Intensive Care Med · 2019-05-06
一句话结论在ARDS患者中,按预测体重归一化的机械功率(norMP)对死亡率的预测区分度优于绝对机械功率,且机器学习无法进一步改善。

该研究纳入8项ARDSNet随机对照试验的5159例急性起病ARDS患者个体数据,按3:1分为训练集和测试集,在测试集中用ROC曲线下面积比较各呼吸机变量的区分度。norMP预测死亡率的区分度显著优于绝对机械功率(DeLong检验p=0.011),梯度提升机未能较norMP进一步改善区分度(p=0.913)。多变量回归显示norMP与ARDS严重程度存在显著交互作用(p<0.05):轻度ARDS中norMP与死亡率无显著关联(OR 0.99;95%CI 0.91-1.07;p=0.862),中度和重度ARDS中norMP与死亡率升高相关(中度OR 1.11;95%CI 1.02-1.23;p=0.021;重度OR 1.13;95%CI 1.03-1.24;p<0.008)。作者认为norMP是与死亡率相关的良好呼吸机变量,尚需进一步实验性试验探究根据norMP调整呼吸机变量能否显著改善临床结局。

要点

  • norMP预测ARDS患者死亡率的区分度显著优于绝对机械功率(DeLong检验p=0.011)。
  • 梯度提升机未能较norMP进一步改善预测区分度(DeLong检验p=0.913)。
  • norMP与ARDS严重程度存在显著交互作用(p<0.05):轻度ARDS中norMP与死亡率无显著关联(OR 0.99;95%CI 0.91-1.07;p=0.862)。
  • 中度ARDS中norMP与死亡率升高相关(OR 1.11;95%CI 1.02-1.23;p=0.021),重度ARDS中亦相关(OR 1.13;95%CI 1.03-1.24;p<0.008)。
  • 作者认为norMP是与死亡率相关的良好呼吸机变量,尚需进一步实验性试验探究根据norMP调整呼吸机变量能否显著改善临床结局。

适用人群与场景

  • 纳入8项ARDSNet随机对照试验中急性起病的ARDS患者,共5159例。
  • 数据按3:1分为训练集和测试集。

研究设计与关键结果

  • 研究类型为基于8项随机对照试验个体患者数据的二次分析,共5159例急性起病ARDS患者。
  • norMP预测死亡率的区分度显著优于绝对机械功率(DeLong检验p=0.011)。
  • 梯度提升机未能较norMP进一步改善区分度(DeLong检验p=0.913)。
  • 多变量回归显示norMP与ARDS严重程度存在显著交互作用(p<0.05)。
  • 轻度ARDS中norMP与死亡率无显著关联(OR 0.99;95%CI 0.91-1.07;p=0.862)。
  • 中度ARDS中norMP与死亡率升高相关(OR 1.11;95%CI 1.02-1.23;p=0.021)。
  • 重度ARDS中norMP与死亡率升高相关(OR 1.13;95%CI 1.03-1.24;p<0.008)。

证据类型、等级与局限

  • 证据类型:基于8项随机对照试验个体患者数据的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为norMP是与死亡率相关的良好呼吸机变量,其预测区分度不能通过复杂机器学习方法进一步改善。
  • 作者指出尚需进一步实验性试验探究根据norMP调整呼吸机变量能否显著改善临床结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Protective mechanical ventilation based on multiple ventilator parameters such as tidal volume, plateau pressure, and driving pressure has been widely used in acute respiratory distress syndrome (ARDS). More recently, mechanical power (MP) was found to be associated with mortality. The study aimed to investigate whether MP normalized to predicted body weight (norMP) was superior to other ventilator variables and to prove that the discrimination power cannot be further improved with a sophisticated machine learning method.

METHODS: The study included individual patient data from eight randomized controlled trials conducted by the ARDSNet. The data was split 3:1 into training and testing subsamples. The discrimination of each ventilator variable was calculated in the testing subsample using the area under receiver operating characteristic curve. The gradient boosting machine was used to examine whether the discrimination could be further improved.

RESULTS: A total of 5159 patients with acute onset ARDS were included for analysis. The discrimination of norMP in predicting mortality was significantly better than the absolute MP (p = 0.011 for DeLong's test). The gradient boosting machine was not able to improve the discrimination as compared to norMP (p = 0.913 for DeLong's test). The multivariable regression model showed a significant interaction between norMP and ARDS severity (p < 0.05). While the norMP was not significantly associated with mortality outcome (OR 0.99; 95% CI 0.91-1.07; p = 0.862) in patients with mild ARDS, it was associated with increased risk of mortality in moderate (OR 1.11; 95% CI 1.02-1.23; p = 0.021) and severe (OR 1.13; 95% CI 1.03-1.24; p < 0.008) ARDS.

CONCLUSIONS: The study showed that norMP was a good ventilator variable associated with mortality, and its predictive discrimination cannot be further improved with a sophisticated machine learning method. Further experimental trials are needed to investigate whether adjusting ventilator variables according to norMP will significantly improve clinical outcomes.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Zhang Z, Zheng B, Liu N, et al. Mechanical power normalized to predicted body weight as a predictor of mortality in patients with acute respiratory distress syndrome. Intensive Care Med. 2019. PMID: 31062050. doi:10.1007/s00134-019-05627-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。